自己免疫疾患診断の世界市場2020-2026:種類別(局所化自己免疫疾患診断、全身性自己免疫疾患診断)、製品別、技術別、地域別

◆英語タイトル:Global Autoimmune Disease Diagnostics Market Size study, by Type (Localized Autoimmune Disease Diagnostic, Systemic Autoimmune Disease Diagnostic,), Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment), Technology (Bridge Therapy, Disease-Modifying Antirheumatic drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, Recombinant Technology) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月10日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、自己免疫疾患診断の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(局所化自己免疫疾患診断、全身性自己免疫疾患診断)分析、製品別分析、技術別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・自己免疫疾患診断の世界市場:種類別(局所化自己免疫疾患診断、全身性自己免疫疾患診断)
・自己免疫疾患診断の世界市場:製品別
・自己免疫疾患診断の世界市場:技術別
・自己免疫疾患診断の世界市場:地域別
・競争状況
【レポートの概要】

Global Autoimmune Disease Diagnostics Market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. The Autoimmune diseases refer to body’s abnormal immune response resulting in the production of antibodies that impact or attack own cells & tissues which leads to destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases such as systematic lupus erythematosus and rheumatoid arthritis prevalent in the global scenario. The Autoimmune disease diagnostics market is primarily driven owing to a high prevalence of autoimmune diseases, escalating awareness, about autoimmune diseases, rise in the number of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key factor in the development and growth of autoimmune disease diagnostics market. For instance: according to the American Autoimmune Related Diseases Association (AARDA), the autoimmune disease impacts around 50 million individuals residing in both urban and semi-urban provinces among which 75% are females in the United States resulting in fueling the demand and adoption of autoimmune disease diagnostics market. However, high capital requirements impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Autoimmune Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high incidence & prevalence of autoimmune diseases and growth in number of research activities on autoimmune diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising aging population along with use of biosensors for autoimmune disease diagnosis would create lucrative growth prospects for the Autoimmune Disease Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories, Inc.
Grifols
Trinity Biotech
Werfen
HYCOR Biomedical
Exagen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Localized Autoimmune Disease Diagnostic
Systemic Autoimmune Disease Diagnostic
By Product:
Drugs
Therapeutic & Monitoring Equipment
Diagnostic Equipment
By Technology:
Bridge Therapy
Disease-Modifying Antirheumatic Drugs (DMARD)
Topical Therapy
Phototherapy
Helminthic Therapy
Recombinant Technology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Autoimmune Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Autoimmune Disease Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Autoimmune Disease Diagnostics Market, by Type, 2018-2026 (USD Billion)
1.2.3. Autoimmune Disease Diagnostics Market, by Product, 2018-2026 (USD Billion)
1.2.4. Autoimmune Disease Diagnostics Market, by Technology, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Autoimmune Disease Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Autoimmune Disease Diagnostics Market Dynamics
3.1. Autoimmune Disease Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Autoimmune Disease Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Autoimmune Disease Diagnostics Market, by Type
5.1. Market Snapshot
5.2. Global Autoimmune Disease Diagnostics Market by Type, Performance – Potential Analysis
5.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
5.4.1. Localized Autoimmune Disease Diagnostic
5.4.2. Systemic Autoimmune Disease Diagnostic
5.4.3.
Chapter 6. Global Autoimmune Disease Diagnostics Market, by Product
6.1. Market Snapshot
6.2. Global Autoimmune Disease Diagnostics Market by Product, Performance – Potential Analysis
6.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
6.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
6.4.1. Drugs
6.4.2. Therapeutic & Monitoring Equipment
6.4.3. Diagnostic Equipment

Chapter 7. Global Autoimmune Disease Diagnostics Market, by Technology
7.1. Market Snapshot
7.2. Global Autoimmune Disease Diagnostics Market by Technology, Performance – Potential Analysis
7.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
7.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
7.4.1. Bridge Therapy
7.4.2. Disease-Modifying Antirheumatic Drugs (DMARD)
7.4.3. Topical Therapy
7.4.4. Phototherapy
7.4.5. Helminthic Therapy
7.4.6. Recombinant Technology
Chapter 8. Global Autoimmune Disease Diagnostics Market, Regional Analysis
8.1. Autoimmune Disease Diagnostics Market, Regional Market Snapshot
8.2. North America Autoimmune Disease Diagnostics Market
8.2.1. U.S. Autoimmune Disease Diagnostics Market
8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Product breakdown estimates & forecasts, 2016-2026
8.2.1.3. Technology breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Autoimmune Disease Diagnostics Market
8.3. Europe Autoimmune Disease Diagnostics Market Snapshot
8.3.1. U.K. Autoimmune Disease Diagnostics Market
8.3.2. Germany Autoimmune Disease Diagnostics Market
8.3.3. Rest of Europe Autoimmune Disease Diagnostics Market
8.4. Asia-Pacific Autoimmune Disease Diagnostics Market Snapshot
8.4.1. China Autoimmune Disease Diagnostics Market
8.4.2. India Autoimmune Disease Diagnostics Market
8.4.3. Japan Autoimmune Disease Diagnostics Market
8.4.4. Rest of Asia Pacific Autoimmune Disease Diagnostics Market
8.5. Latin America Autoimmune Disease Diagnostics Market Snapshot
8.5.1. Brazil Autoimmune Disease Diagnostics Market
8.5.2. Mexico Autoimmune Disease Diagnostics Market
8.6. Rest of The World Autoimmune Disease Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Siemens Healthineers
9.2.3. Abbott Laboratories
9.2.4. Danaher Corporation
9.2.5. Bio-Rad Laboratories, Inc.
9.2.6. Grifols
9.2.7. Trinity Biotech
9.2.8. Werfen
9.2.9. HYCOR Biomedical
9.2.10. Exagen Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[自己免疫疾患診断の世界市場2020-2026:種類別(局所化自己免疫疾患診断、全身性自己免疫疾患診断)、製品別、技術別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆